Table 1.
Biological activities of transmembrane TNF-α as a ligand
| Target | Function | References |
|---|---|---|
| Tumour cells (various types) | Cytotoxicity | [32–35, 38, 39, 43] |
| HIV-infected lymphocyte | Cell death | [44] |
| Intracellular parasite-infected macrophage | Inhibit the growth of intracellular pathogens | [45–49] |
| Mycobacterium infection | T-cell and macrophage migration, granuloma formation | [52–55] |
| Monocyte | IL-10 production | [70] |
| B cell | Proliferation, Ig production | [58–64] |
| T cell | HLA-DR and CD25 expression, GM-CSF production | [19] |
| NK cell | Enhancement of cytotoxic activity | [65] |
| Endothelial cell | Cell death, induction of pro-coagulant agents, adhesion molecules and pro-inflammatory cytokines | [42, 19, 56, 57] |
| Adipose tissue | Inhibition of adipocyte differentiation, local insulin resistance | [66, 67] |
| Heart | Concentric cardiac hypertrophy | [68, 69] |
| Lung | Interstitial inflammation | [36, 37] |
| Liver | Hepatitis | [40, 41] |